🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsDosing & ProtocolsSemaglutide PK modeling — anyone have experience? Page 4

Semaglutide PK modeling — anyone have experience?

anna.melb_AU Fri, Jan 31, 2025 at 11:07 AM 31 replies 2,196 viewsPage 4 of 7
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Feb 10, 2025 at 7:29 AM#16

From the other side of the consultation, briefly. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

29 2DataDave, Dr.GutHealth, amsterdam_pete and 26 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Feb 11, 2025 at 2:25 PM#17

Clinical perspective, offered as context rather than as advice. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

Ask again with the specifics and you will get a better answer than this one.

30 3InsuranceTom, WendyG_ATL, SaraMom3 and 27 others
Reply Quote Save Share Report
LeilaHI
Member
167
789
Jan 2025
Honolulu, HI
Feb 12, 2025 at 9:21 PM#18
Dr.PathRoch said:
The useful move here is to separate what is established from what is widely repeated.

This matches mine closely enough to be worth saying so. Steady state is the thing most people miss. The terminal half-life is about a week, so every dose step takes four to five weeks to fully express itself. Judging a step at day ten is judging the ascent, not the plateau, and it is the single commonest reason people escalate before they needed to.

Last edited: Feb 13, 2025 at 2:21 AM
31 4mike_nyc, VendorMark, COA_Karl and 28 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
DerekSJ_a1c
Member
378
1,678
Aug 2024
San Jose, CA
Feb 14, 2025 at 4:16 AM#19
Dr.PathRoch said:
The useful move here is to separate what is established from what is widely repeated.

Coming at Dr.PathRoch’s question from a different direction. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

Last edited: Feb 14, 2025 at 9:16 AM
32 5traveltech_sara, AttorneyGrant, DebRD_ATL and 29 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Feb 15, 2025 at 11:10 AM#20

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. Carry on.

4 2PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 1 other
Reply Quote Save Share Report

Similar Threads

Micro-dosing semaglutide — is sub-therapeutic dosing effective?16 replies
Injection technique: subcutaneous depot formation and absorption8 replies
Semaglutide PK modeling — when to time your injection12 replies
Reconstitution calculator — compounded peptide dosing math7 replies
Half-life implications for missed doses — PK-based guidance5 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register